AEM vs AGI

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

The Advanced Deterministic Scorecard reveals a mixed financial profile: the Piotroski F-Score of 4/9 indicates borderline financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite strong profitability metrics and robust earnings growth, elevated valuation multiples and inconsistent quarterly earnings surprises weigh on sustainability. The stock trades significantly above the Graham Number of $16.89 and near the intrinsic value of $38.94, suggesting limited margin of safety. Analysts maintain a strong_buy consensus, but technical trend and insider sentiment are weak, indicating caution despite favorable sector-relative fundamentals.